Terms of Use

These Terms of Use (together with the documents to which these terms refer) provides the terms and conditions on which you may make use of the international Symbicort® website ("Terms of Use"). Please read these Terms of Use carefully before you start to use the website. By using this website, you indicate that you accept these Terms of Use and that you agree to abide by them. If you do not agree to these Terms of Use, please refrain from using this website.

This website is intended for healthcare professionals only. Product information on this website is intended for general information purposes.

The download and use of RSS feeds from this website is subject to our RSS Feed Licence terms. The download and use of digital audio and/or video content and/or podcasts from this website is subject to our Podcast Licence terms. In the event of any conflict between these Terms of Use and the RSS Feeds Licence and/or the Podcast Licence, these Terms of Use prevail.

Information About Us

This international website is operated by AstraZeneca UK Limited ("AstraZeneca"), a private limited company registered in England and Wales under company number 03674842, with registered office at 2 Kingdom Street, London W2 6BD. The main worldwide locations and trading addresses of the AstraZeneca Group are listed at http://www.astrazeneca.com/about-us/addresses/.

References to "AstraZeneca" and “Group” are references to AstraZeneca UK Limited and its Affiliates. In these Terms of Use "Affiliates" means any corporation or other business entity controlling, controlled by or under common control with AstraZeneca UK Limited from time to time and, for the purposes of this definition, "control" shall mean direct or indirect ownership of (i) fifty per cent (50%) or more of the voting securities or voting interest in such corporation or other entity; or (ii) fifty per cent (50%) or more of the interest in the profit or income in the case of a business entity other than a corporation; or (iii) in the case of a partnership, any other comparable interest in the general partner.

Disclaimer

THIS WEBSITE IS INTENDED FOR HEALTHCARE PROFESSIONALS ONLY. IT IS NOT INTENDED TO BE USED BY PATIENTS.

Whilst AstraZeneca has taken reasonable care in compiling this website, AstraZeneca takes no responsibility for any action taken by any person or organisation, wherever they are based, as a result, direct or otherwise, of information contained in or accessed through this website whether such information is provided by AstraZeneca or by a third party. Nothing on this website should be construed as the giving of advice or the making of any recommendation and this website should not be relied upon as the basis for any decision or action.

As a result of ongoing medical advances and developments, the information on this website may not always be completely up to date and, for this reason, such information is provided on an "AS IS" and "AS AVAILABLE" basis. ASTRAZENECA MAKES NO WARRANTIES, REPRESENTATIONS OR GIVE ANY UNDERTAKINGS EITHER EXPRESS OR IMPLIED ABOUT ANY OF THE CONTENT OF THIS WEBSITE (INCLUDING, WITHOUT LIMITATION, THE TIMELINESS, CURRENCY, ACCURACY, COMPLETENESS OR FITNESS FOR ANY PARTICULAR PURPOSE OF SUCH CONTENT OR THAT THE RESULTS WHICH MAY BE OBTAINED FROM THE USE OF THE WEBSITE WILL BE ERROR FREE OR RELIABLE).

You agree that the use of information obtained or downloaded from or through this website is at your sole discretion and risk. Some jurisdictions do not allow the exclusion of implied warranties in which case the above will not apply in such jurisdictios. The information contained on this website should is not and should not be construed as medical advice. The product information on Symbicort® mentioned on this website is based on the Summary of Product Characteristics (SPC) for Symbicort® in the UK, and the product information may vary by country. A reference to Symbicort® on this website does not imply that Symbicort® is or will be available in every location. As a healthcare professional you should refer to your local prescribing information and check with local medical resources and regulatory authorities for information appropriate to your country.

Nothing on this website shall be deemed to constitute an invitation to invest or otherwise deal in shares, ADRs or other securities in AstraZeneca PLC. Actual results and developments may be materially different from any forecast, opinion or expectation expressed on this website and the past performance of the price of securities must not be relied on as a guide to their future performance.

Disclaimer of Liability

To the extent permitted by law, AstraZeneca, other members of our Group (as defined below) and third parties connected to us hereby expressly exclude:

• All conditions, warranties and other terms which might otherwise be implied by statute, common law or the law of equity; and
• Any liability for any direct, indirect or consequential loss or damage incurred by any user in connection with our website or in connection with the use, inability to use, or results of the use of our website, any websites linked to it and any materials posted on it, including, without limitation any liability for (i) loss of income or revenue, (ii) loss of business, (iii) loss of profits or contracts, (iv) loss of anticipated savings, (v) loss of data, (vi) loss of goodwill, (vii) wasted management or office time; and (viii) for any other loss or damage of any kind, however arising and whether caused by tort (including negligence), breach of contract or otherwise, even if foreseeable.

This does not affect AstraZeneca liability for death or personal injury arising from AstraZeneca's negligence, nor AstraZeneca's liability for fraudulent misrepresentation or misrepresentation as to a fundamental matter, nor any other liability which cannot be excluded or limited under applicable law.

AstraZeneca does not warrant that functions contained in this website will be uninterrupted or error free, that defects will be corrected, or that this website or the server that makes it available are free of viruses or bugs.

Trademarks, Copyright and Intellectual Property Rights

The intellectual property rights in this website, including without limitation, in all documents, files, text, images, RSS feeds, audio files, podcasts, video files, flash tutorials, graphics, devices and code contained in it and in this website's general "look and feel", is owned by AstraZeneca, its Affiliates or its third party providers. These works are protected by copyright laws and treaties around the world. All such rights are reserved.

You are authorised to make a single copy and to print extracts or documents from this website (except for any third party owned content which has been identified as such) for your non-commercial use provided any such copy or print retains all copyright or other proprietary notices and any disclaimer contained within them.

All product names referred to on this website are trademarks of AstraZeneca or its Affiliates, except for those marks which are indicated as owned by other companies and all rights are reserved. AstraZeneca’s trademarks may not be used or reproduced without the prior written consent of AstraZeneca.

Other than as specifically mentioned above, reproduction of part or all of the contents of this website in any form, including framing, creating any derivative work based on this website and or its content, incorporation into other websites, electronic retrieval systems or publications is prohibited. You may not use any diagrams, illustrations, photographs, video or audio sequences or any graphics separately from any accompanying text. No links to this website may be included in any other website without our prior written permission.

AstraZeneca cannot guarantee that you have any right to use third party owned content which is available on this website and you must obtain permission from the third party owner before using or downloading such content. Content which is copyright protected may not be changed nor may any author attribution notice or copyright notice appearing on such content be altered without first obtaining the appropriate consents.

Except for the limited permission set out above, nothing on this website should be construed as granting any other right or licence.

Right to use information supplied by user

In the event that you submit any material for inclusion on this website (including without limitation, personal information, know-how, comments, ideas, questions, techniques, abstracts or similar), you agree (i) that such material will not be deemed to be confidential (ii) that such material will not be deemed to be proprietary and (iii) to grant to the AstraZeneca Group an irrevocable, worldwide, perpetual, royalty-free, non-exclusive licence to use, disclose, copy, modify, adapt, publicly display and translate all or any of such material for any purpose whatsoever without restriction. We reserve the right, in our absolute discretion, to remove or delete, without notice, any material you submit for inclusion on this website. We also have the right to disclose your identity to any third party who is claiming that any material posted or uploaded by you to our website constitutes a violation of their intellectual property rights, or of their right to privacy. Any personal information we collect about you will be used in accordance with our Privacy Policy.

Viruses, hacking and other offences

You must not misuse our website by knowingly introducing viruses, trojans, worms, logic bombs or other material which is malicious or technologically harmful. You must not attempt to gain unauthorised access to our website, the server on which our website is stored or any server, computer or database connected to our website. You must not attack our website via a denial-of-service attack or a distributed denial-of service attack.

By breaching this provision, you would commit a criminal offence under the UK Computer Misuse Act 1990. AstraZeneca will report any such breach to the relevant law enforcement authorities and we will co-operate with those authorities by disclosing your identity to them. In the event of such a breach, your right to use our website will cease immediately.

AstraZeneca will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of our website or to your downloading of any material posted on it, or on any website linked to it. In accordance with good computing practice, you are advised to virus check all materials and/or content accessed and/or downloaded from this website using commercially available, up to date virus checking software.

Third party websites and content

This website may contain third party owned content (e.g. articles, image libraries, data feeds or abstracts) and may also include hypertext links to third party owned websites. AstraZeneca provides such third party content and links as a courtesy to our users. Links are provided for your information only. AstraZeneca has no control over any third party owned websites or content referred to, accessed by or available on this website and, therefore, we do not endorse, sponsor, recommend or otherwise accept any responsibility for such third party websites or content or for the availability of such websites. In particular, AstraZeneca do not accept any liability arising out of any allegation that any third party owned content (whether published on this, or any other, website) infringes the intellectual property rights of any person or any liability arising out of any information or opinion contained on such third party website or content.

Changes to this website

AstraZeneca reserves the right to change any part of this website or these Terms of Use at any time without notice. Any changes to these Terms of Use shall take effect from the next time you access this website. Notwithstanding the above, AstraZeneca shall not be obliged to keep this website up to date. AstraZeneca reserves the right to discontinue this website and any time without prior notice.

Codes of Pharmaceutical Marketing Practices

Any promotional content of this international website, has been prepared with reference to the IFPMA Code of Pharmaceutical Marketing Practices, as amended, and the ABPI Code of Practice for the Pharmaceutical Industry, as amended. In using this website you agree that any concerns you may have about the content will be taken up first with AstraZeneca. Then if you are not satisfied with our response, you may submit a complaint to the IFPMA, Geneva, Switzerland or PMCPA, London, UK. Any complaints concerning promotional content, which is specific to one country, may alternatively be submitted to the pharmaceutical manufacturers association in the country concerned.

Jurisdiction and Applicable Law

The English courts will have exclusive jurisdiction over any claim arising from, or related to, a visit to AstraZeneca website although we retain the right to bring proceedings against you for breach of these conditions in your country of residence or any other relevant country. These Terms of Use are governed by English law.

Review period : 12 months
Last reviewed : July 2011